Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha GM Roemer, MS, Ranjana H Advani, MD, Azra H. Ligon, PhD, Yasodha Natkunam, MD PhD, Robert A Redd, MS, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Bjoern Chapuy, MD PhD, Daphne de Jong, MD PhD, Richard T. Hoppe, MD, Donna S Neuberg, ScD, Scott J Rodig, MD PhD, Margaret A. Shipp, MD

Blood (2015) 126 (23): 176.

https://doi.org/10.1182/blood.V126.23.176.176

Published: 2015

Journal Articles

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Blood (2014) 124 (21): 74.

https://doi.org/10.1182/blood.V124.21.74.74

Published: 2014

Journal Articles

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

Jan-Lukas Robertus, MD, Miao Wang, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Rikst Nynke Schakel, MSc, Daphne de Jong, MD PhD, Rogier M. Reijmers, MSc, Steven T. Pals, MD PhD, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 3586.

https://doi.org/10.1182/blood.V110.11.3586.3586

Published: 2007

Journal Articles

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

JanLukas Robertus, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Daphne de Jong, MD PhD, Marije Booman, Ir, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 1566.

https://doi.org/10.1182/blood.V110.11.1566.1566

Published: 2007

Journal Articles

First Report of the HOVON 45: A Phase II Study with Rituximab, High Dose Ara-C and Autologous Stem Cell Transplantation in the Primary Treatment of Mantle Cell Lymphoma.

Mars B. Van’t Veer, MD, PhD, Annelise Notenboom, PhD, Marius McKenzie, MD,PhD, Hanneke Kluin-Nelemans, MD,PhD, Rien van Oers, MD,PhD, Jose Zijlstra, MD, Daphne de Jong, MD,PhD, Pieter Sonneveld, MD,PhD, Anton Hagenbeek, MD,PhD

Blood (2006) 108 (11): 2734.

https://doi.org/10.1182/blood.V108.11.2734.2734

Published: 2006

Journal Articles

Gene Expression Profiling Can Predict Responsiveness to Chemotherapy in Patients with Transformation of Follicular Lymphoma.

Marie Jose Kersten, MD, PhD, Annuska M. Glas, PhD, Leonie J. Delahaye, Robby E. Kibbelaar, MD, PhD, Han H. van Krieken, MD, PhD, Philip M. Kluin, MD, PhD, Laura van ‘t Veer, PhD, Daphne de Jong, MD, PhD

Blood (2006) 108 (11): 823.

https://doi.org/10.1182/blood.V108.11.823.823

Published: 2006

Journal Articles

The Novel Cancer Drug Seliciclib Engages the Mitochondrial Apoptosis Pathway Via the Mcl-1/Noxa Axis in CLL.

Delfine Hallaert, Rene Spijker, Ingrid A.M. Derks, Margot Jak, MD, Bart de Goeij, Jan Paul de Boer, MD, PhD, Daphne de Jong, MD, PhD, Simon R. Green, Rene van Lier, MD, PhD, Eric Eldering, PhD, Marinus H.J. Van Oers, MD, PhD

Blood (2005) 106 (11): 2983.

https://doi.org/10.1182/blood.V106.11.2983.2983

Published: 2005

Journal Articles

Low Dose Radiation Induces a Highly Effective p53 Response and Rapid Tumor Regression in Follicular Lymphoma.

Laurent Knoops, MD, PhD, Rick L. Haas, MD, Sanne de Kemp, Annegien Broeks, PhD, Laura J. van ‘t Veer, PhD, Daphne de Jong, MD, PhD

Blood (2005) 106 (11): 354.

https://doi.org/10.1182/blood.V106.11.354.354

Published: 2005

Journal Articles

Gene Expression Profiles Are Best Suited To Assess Present Though Not Future Clinical Aggressiveness in Follicular Lymphoma.

Annuska M. Glas, PhD, Marie Jose Kersten, MD, PhD, Leonie Delahaye, Robby E. Kibbelaar, MD, PhD, Joannes H.J.M. Van Krieken, MD, PhD, Philip M. Kluin, MD, PhD, Laura J. van ‘t Veer, PhD, Daphne de Jong, MD, PhD

Blood (2004) 104 (11): 698.

https://doi.org/10.1182/blood.V104.11.698.698

Published: 2004

NARROW

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

First Report of the HOVON 45: A Phase II Study with Rituximab, High Dose Ara-C and Autologous Stem Cell Transplantation in the Primary Treatment of Mantle Cell Lymphoma.

Gene Expression Profiling Can Predict Responsiveness to Chemotherapy in Patients with Transformation of Follicular Lymphoma.

The Novel Cancer Drug Seliciclib Engages the Mitochondrial Apoptosis Pathway Via the Mcl-1/Noxa Axis in CLL.

Low Dose Radiation Induces a Highly Effective p53 Response and Rapid Tumor Regression in Follicular Lymphoma.

Gene Expression Profiles Are Best Suited To Assess Present Though Not Future Clinical Aggressiveness in Follicular Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only